The Cardioband transcatheter annular reduction system.

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Devices

Background:

• Mitral and tricuspid regurgitation are significant conditions often treated with annular reduction surgery.
• The Cardioband system is a novel catheter-delivered device designed to replicate surgical annular reduction.
• Degenerative and functional mitral regurgitation necessitate effective treatment strategies.

Purpose of the Study:

• To evaluate the safety and efficacy of the Cardioband system for treating functional mitral regurgitation (FMR).
• To assess the impact of Cardioband implantation on quality of life and exercise capacity.
• To explore the early clinical experience of the Cardioband system in tricuspid regurgitation.

Main Methods:

• The Cardioband system uses sequential anchors and transesophageal guidance for annular reduction.
• The device is deployed from trigone to trigone, with subsequent contraction to reduce regurgitation.
• Initial clinical experience and ongoing trials like the ACTIVE Trial are used for evaluation.

Main Results:

• The Cardioband system demonstrated safe deployment in patients with significant functional mitral regurgitation.
• Durable reduction in mitral regurgitation was observed, leading to improved quality of life.
• Improvements in exercise capacity were noted in patients treated with the Cardioband system.
• Early results for tricuspid regurgitation treatment are also promising.

Conclusions:

• The Cardioband system provides a safe and effective catheter-based solution for functional mitral regurgitation.
• The device shows potential for durable regurgitation reduction and significant patient benefit.
• Further investigation in the ACTIVE Trial will compare Cardioband to guideline-directed medical therapy for FMR.